If I had asked people what they had wanted, they would have said “Faster Horses”
Henry Ford
Superficially there are many types of COVID tests pushed forward on seemingly a daily basis. Antibody Tests:
Rapid diagnostic tests (RDT); Enzyme-linked immunosorbent assay (ELISA); Neutralization assays; Chemiluminescent immunoassay; tests for IgG, IgM, and IgA, Sniff tests; chest x-ray; Serology, RT-PCR etc etc. These vary in much the same way that different types of horse tackle or saddle might. Our test is as different as a car or an aeroplane is from a group of new horse saddles on display.
We are the only fast test that looks at the body’s own response through the T-Cells of the Lymphatic system – a system identified in TCM, Traditional Chinese Medicine perhaps as long ago as the Shang dynasty 3400 years ago. Our peer-reviewed and patented method is
- Up to 20 times more effective at preventing the spread of COVID and SARS-CoV-2
- Takes only 30 seconds to 3 minutes depending on specific hardware
- Is more effective than PCR as it detects COVID before visible symptoms
- Depending on pricing model can be offered at half the price of PCR with substantially higher profits than either PCR or Antibody tests
- Very rapid rollout. Can have the algorithms installed and ready in days. The devices are ordered from China. Small volumes are off the shelf. Larger to order in weeks. Our rollout in Italy took 4 days. For Japan, it took 2 weeks from order to commercial use.
- British Government backed and rated as outstanding. It was only fully proven at the stage when the government wanted to downplay COVID for political reasons and disbanded the government advisory groups such as SAGE (UK Scientific Advisory Group for Emergencies) who we worked with.
The solution is useable not just for future variants of concern, but also for future pandemics and as a general blood diagnosis method..
It involves very low investment and high return as it uses existing Chinese-made devices (originally Swedish-made) with a special AI system which will not need upfront investment.
Organizations that can integrate into existing CVID test centres can repay the investment in days.
The inventor of the test (Dr Baker) has a Doctorate from Oxford University in Cancer Research, Degree from Imperial College and is a former Cambridge Research Fellow, led the team that won the Global Coronahack ahead of 1000 other scientists and laboratories for the invention of this method, previously worked as CTO on an AI project used by over 100 million people in the EU and on drug development in a Johnson and Johnson company on a project with grossed $43Bn USD.
Team from Cambridge University: An institution with more Nobel Prizes than the country of Germany https://www.cam.ac.uk/research/research-at-cambridge/nobel-prize and Europe’s number one university https://edurank.org/geo/eu/
Operating company founded in UK in 2010 for the development of medical research algorithms. Parent company in BVI
Massively cheaper, faster, saves more lives, reduces lockdowns to one tenth or less, more more profitable
Current lateral flow and PCR are estimated to have contributed a 10% to 28% reduction in R.
Characteristic Differential Leucocyte Count (CLDC) – the Cambridge Rapid Test – reduces R – the infection rate by 95%-97%